News
A study on fasting and the ketogenic diet uncovers a newfound weakness in pancreatic tumors, making them more susceptible to ...
Pancreatic cancer is a leading cause of cancer-related death, with a five-year survival rate of 13%. The high mortality is ...
3d
Medindia on MSNBlood Test Ends Pancreatic Cancer’s Game of Hide and Seek!Blood tests use protease activity to identify pancreatic cancer early, offering hope for timely diagnosis and better survival ...
New research from SAHMRI and Flinders University has shed light on how the decades-old antipsychotic drug, trifluoperazine ...
Now Zeskind and his clinical-stage biotech company are attempting to try something new in the field of pancreatic cancer. Instead of shutting down a pathway round the clock and then dosing a ...
12d
News-Medical.Net on MSNGOT2 as a metabolic and immunologic target in pancreatic cancerA new wave of scientific interest is spotlighting GOT2—glutamic-oxaloacetic transaminase 2—as a compelling therapeutic target in the fight against pancreatic cancer, one of the most lethal and ...
Gastroenterologists are uniquely positioned to expand their critical role in detecting and treating gastrointestinal diseases ...
A new study has found increased risks for liver, pancreatic, and bowel cancers following a new diagnosis of type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results